Sickle cell trait and risk of cognitive impairment in African-Americans: The REGARDS cohort
Background: Sickle cell anemia may be associated with cognitive dysfunction, and some complications of sickle cell anemia might affect those with sickle cell trait (SCT), so we hypothesized that SCT is a risk factor for cognitive impairment. Methods: The Reasons for Geographic and Racial Differences...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-05-01
|
Series: | EClinicalMedicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S258953701930077X |
id |
doaj-5c05cf3f915e4f87a66054ccd3502bcd |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Christina R. Cahill Justin M. Leach Leslie A. McClure Marguerite Ryan Irvin Neil A. Zakai Rakhi Naik Frederick Unverzagt Virginia G. Wadley Hyacinth I. Hyacinth Jennifer Manly Suzanne E. Judd Cheryl Winkler Mary Cushman |
spellingShingle |
Christina R. Cahill Justin M. Leach Leslie A. McClure Marguerite Ryan Irvin Neil A. Zakai Rakhi Naik Frederick Unverzagt Virginia G. Wadley Hyacinth I. Hyacinth Jennifer Manly Suzanne E. Judd Cheryl Winkler Mary Cushman Sickle cell trait and risk of cognitive impairment in African-Americans: The REGARDS cohort EClinicalMedicine |
author_facet |
Christina R. Cahill Justin M. Leach Leslie A. McClure Marguerite Ryan Irvin Neil A. Zakai Rakhi Naik Frederick Unverzagt Virginia G. Wadley Hyacinth I. Hyacinth Jennifer Manly Suzanne E. Judd Cheryl Winkler Mary Cushman |
author_sort |
Christina R. Cahill |
title |
Sickle cell trait and risk of cognitive impairment in African-Americans: The REGARDS cohort |
title_short |
Sickle cell trait and risk of cognitive impairment in African-Americans: The REGARDS cohort |
title_full |
Sickle cell trait and risk of cognitive impairment in African-Americans: The REGARDS cohort |
title_fullStr |
Sickle cell trait and risk of cognitive impairment in African-Americans: The REGARDS cohort |
title_full_unstemmed |
Sickle cell trait and risk of cognitive impairment in African-Americans: The REGARDS cohort |
title_sort |
sickle cell trait and risk of cognitive impairment in african-americans: the regards cohort |
publisher |
Elsevier |
series |
EClinicalMedicine |
issn |
2589-5370 |
publishDate |
2019-05-01 |
description |
Background: Sickle cell anemia may be associated with cognitive dysfunction, and some complications of sickle cell anemia might affect those with sickle cell trait (SCT), so we hypothesized that SCT is a risk factor for cognitive impairment. Methods: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) study enrolled a national cohort of 30,239 white and black Americans from 2003 to 7, who are followed every 6 months. Baseline and annual global cognitive function testing used the Six-Item Screener (SIS), a validated instrument (scores range 0–6; ≤4 indicates cognitive impairment). Participants with baseline cognitive impairment and whites were excluded. Logistic regression was used to calculate the association of SCT with incident cognitive impairment, adjusted for risk factors. Linear mixed models assessed multivariable-adjusted change in test scores on a biennially administered 3-test battery measuring learning, memory, and semantic and phonemic fluency. Findings: Among 7743 participants followed for a median of 7·1 years, 85 of 583 participants with SCT (14·6%) developed incident cognitive impairment compared to 902 of 7160 (12·6%) without SCT. In univariate analysis, the odds ratio (OR) of incident cognitive impairment was 1·18 (95% CI: 0·93, 1·51) for those with SCT vs. those without. Adjustment did not impact the OR. There was no difference in change on 3-test battery scores by SCT status (all p > 0·11). Interpretation: In this prospective cohort study of black Americans, SCT was not associated with incident cognitive impairment or decline in test scores of learning, memory and executive function. Funding: National Institutes of Health, American Society of Hematology. Keywords: Sickle cell trait, Cognitive dysfunction, Cognition, Prospective studies, Risk factors, Epidemiology |
url |
http://www.sciencedirect.com/science/article/pii/S258953701930077X |
work_keys_str_mv |
AT christinarcahill sicklecelltraitandriskofcognitiveimpairmentinafricanamericanstheregardscohort AT justinmleach sicklecelltraitandriskofcognitiveimpairmentinafricanamericanstheregardscohort AT leslieamcclure sicklecelltraitandriskofcognitiveimpairmentinafricanamericanstheregardscohort AT margueriteryanirvin sicklecelltraitandriskofcognitiveimpairmentinafricanamericanstheregardscohort AT neilazakai sicklecelltraitandriskofcognitiveimpairmentinafricanamericanstheregardscohort AT rakhinaik sicklecelltraitandriskofcognitiveimpairmentinafricanamericanstheregardscohort AT frederickunverzagt sicklecelltraitandriskofcognitiveimpairmentinafricanamericanstheregardscohort AT virginiagwadley sicklecelltraitandriskofcognitiveimpairmentinafricanamericanstheregardscohort AT hyacinthihyacinth sicklecelltraitandriskofcognitiveimpairmentinafricanamericanstheregardscohort AT jennifermanly sicklecelltraitandriskofcognitiveimpairmentinafricanamericanstheregardscohort AT suzanneejudd sicklecelltraitandriskofcognitiveimpairmentinafricanamericanstheregardscohort AT cherylwinkler sicklecelltraitandriskofcognitiveimpairmentinafricanamericanstheregardscohort AT marycushman sicklecelltraitandriskofcognitiveimpairmentinafricanamericanstheregardscohort |
_version_ |
1725835025698521088 |
spelling |
doaj-5c05cf3f915e4f87a66054ccd3502bcd2020-11-24T22:02:35ZengElsevierEClinicalMedicine2589-53702019-05-01112733Sickle cell trait and risk of cognitive impairment in African-Americans: The REGARDS cohortChristina R. Cahill0Justin M. Leach1Leslie A. McClure2Marguerite Ryan Irvin3Neil A. Zakai4Rakhi Naik5Frederick Unverzagt6Virginia G. Wadley7Hyacinth I. Hyacinth8Jennifer Manly9Suzanne E. Judd10Cheryl Winkler11Mary Cushman12Larner College of Medicine at the University of Vermont, Burlington, VT, United States of AmericaDepartment of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, United States of AmericaDepartment of Epidemiology and Biostatistics, Dornsife School of Public Health, Drexel University, Philadelphia, PA, United States of AmericaDepartment of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, United States of AmericaDepartment of Medicine, Larner College of Medicine at the University of Vermont, Burlington, VT, United States of America; Department of Pathology and Laboratory Medicine, Larner College of Medicine at the University of Vermont, Burlington, VT, United States of AmericaDepartment of Medicine, Johns Hopkins University, Baltimore, MD, United States of AmericaDepartment of Psychiatry, Indiana University School of Medicine, Indianapolis, IN, United States of AmericaDepartment of Medicine, Division of Gerontology Geriatrics and Palliative Care, University of Alabama at Birmingham, Birmingham, AL, United States of AmericaAflac Cancer and Blood Disorder Center of Children's Healthcare of Atlanta, Department of Pediatrics, Emory University, Atlanta, GA, United States of AmericaThe Taub Institute for Research in Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, NY, United States of AmericaDepartment of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, United States of AmericaMolecular Genetics Epidemiology Section, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, United States of AmericaDepartment of Medicine, Larner College of Medicine at the University of Vermont, Burlington, VT, United States of America; Department of Pathology and Laboratory Medicine, Larner College of Medicine at the University of Vermont, Burlington, VT, United States of America; Corresponding author at: Department of Medicine, Larner College of Medicine at the University of Vermont, 360 South Park Drive, Colchester, VT 05446, United States of America.Background: Sickle cell anemia may be associated with cognitive dysfunction, and some complications of sickle cell anemia might affect those with sickle cell trait (SCT), so we hypothesized that SCT is a risk factor for cognitive impairment. Methods: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) study enrolled a national cohort of 30,239 white and black Americans from 2003 to 7, who are followed every 6 months. Baseline and annual global cognitive function testing used the Six-Item Screener (SIS), a validated instrument (scores range 0–6; ≤4 indicates cognitive impairment). Participants with baseline cognitive impairment and whites were excluded. Logistic regression was used to calculate the association of SCT with incident cognitive impairment, adjusted for risk factors. Linear mixed models assessed multivariable-adjusted change in test scores on a biennially administered 3-test battery measuring learning, memory, and semantic and phonemic fluency. Findings: Among 7743 participants followed for a median of 7·1 years, 85 of 583 participants with SCT (14·6%) developed incident cognitive impairment compared to 902 of 7160 (12·6%) without SCT. In univariate analysis, the odds ratio (OR) of incident cognitive impairment was 1·18 (95% CI: 0·93, 1·51) for those with SCT vs. those without. Adjustment did not impact the OR. There was no difference in change on 3-test battery scores by SCT status (all p > 0·11). Interpretation: In this prospective cohort study of black Americans, SCT was not associated with incident cognitive impairment or decline in test scores of learning, memory and executive function. Funding: National Institutes of Health, American Society of Hematology. Keywords: Sickle cell trait, Cognitive dysfunction, Cognition, Prospective studies, Risk factors, Epidemiologyhttp://www.sciencedirect.com/science/article/pii/S258953701930077X |